Advertisement
Medical milestone: U.S. OKs marijuana-based drug for seizures

Medical milestone: U.S. OKs marijuana-based drug for seizures

By Associated Press  |  June 25, 2018

U.S. health regulators on Monday approved the first prescription drug made from marijuana, a milestone that could spur more research into a drug that remains illegal under federal law, despite growing legalization for recreational and medical use.

Gottlieb sets a new standard for FDA commissioner

Gottlieb sets a new standard for FDA commissioner

By Alex Kacik  |  June 16, 2018

FDA Commissioner Dr. Scott Gottlieb has quieted many of his critics. An unprecedented level of transparency and public disclosure has garnered support from across the industry.

Senate committee to advance Creates Act this week

Senate committee to advance Creates Act this week

By Susannah Luthi  |  June 05, 2018

The Senate is clearing the way this week for a bipartisan bill supported by insurers and provider groups aimed at easing generic drugs' entry into the market, although the legislation's future in the House and Senate is unclear.

IHI forms nationwide patient safety committee

IHI forms nationwide patient safety committee

By Maria Castellucci  |  May 22, 2018

The Institute for Healthcare Improvement, CMS, FDA, Joint Commission and others joined forces to create an action plan that relies on a "total systems approach" to uniformly apply safety principles across the industry.

FDA explores requiring drug price disclosures in commercials

FDA explores requiring drug price disclosures in commercials

By Virgil Dickson  |  May 15, 2018

The FDA is exploring whether it can legally force drugmakers to disclose prices in consumer advertising. President Donald Trump has called the move a key strategy to give companies incentives to keep prices low.

FDA looks to regulate digital drug products

FDA looks to regulate digital drug products

By Virgil Dickson  |  April 26, 2018

As pharmaceutical companies develop digital tools to combat medication adherence issues, the Food and Drug Administration is considering regulating them.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print